Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast and Upcoming Conference Presentation
April 28, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, April 28, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
March 08, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, March 08, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces Upcoming Fourth Quarter and Full Year 2015 Financial Results Conference Call With Webcast
February 24, 2016 08:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Feb. 24, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure, will...
Vital Therapies Receives FDA Guidance; Announces Upcoming Launch of VTL-308 Phase 3 Trial
November 19, 2015 08:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure,...
Vital Therapies Announces Late Breaker and Poster Presentations at the Annual Meeting of the American Association for the Study of Liver Disease
November 18, 2015 08:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure,...
Vital Therapies Announces Third Quarter 2015 Financial Results and Provides Corporate Update
November 05, 2015 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure, today...
Vital Therapies Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriter's Option to Purchase Additional Shares
October 28, 2015 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing the ELAD® System, a cell-based therapy targeting the treatment of liver...
Vital Therapies Announces Pricing of Public Offering of Common Stock
October 22, 2015 23:59 ET
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing the ELAD® System, a cell-based therapy targeting the treatment of liver...
Vital Therapies Announces Proposed Public Offering of Common Stock
October 22, 2015 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing the ELAD® System, a cell-based therapy targeting the treatment of liver...
Vital Therapies Provides Corporate Update and Announces Date of Third Quarter 2015 Financial Results
October 16, 2015 08:00 ET
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 16, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure, today...